State Street Corp Bio Xcel Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 77,149 shares of BTAI stock, worth $43,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,149
Previous 124,749 38.16%
Holding current value
$43,974
Previous $159,000 70.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.53 - $1.34 $25,228 - $63,784
-47,600 Reduced 38.16%
77,149 $47,000
Q2 2024

Aug 14, 2024
SELL
$1.14 - $2.97 $387,781 - $1.01 Million
-340,159 Reduced 73.17%
124,749 $159,000
Q1 2024

May 15, 2024
BUY
$1.95 - $4.04 $47,923 - $99,287
24,576 Added 5.58%
464,908 $1.31 Million
Q4 2023

Feb 14, 2024
BUY
$2.32 - $5.51 $70,699 - $167,911
30,474 Added 7.44%
440,332 $1.3 Million
Q3 2023

Nov 14, 2023
SELL
$2.49 - $11.85 $4.14 Million - $19.7 Million
-1,662,341 Reduced 80.22%
409,858 $1.04 Million
Q2 2023

Aug 14, 2023
BUY
$6.39 - $28.58 $1.99 Million - $8.9 Million
311,516 Added 17.69%
2,072,199 $13.8 Million
Q1 2023

May 15, 2023
BUY
$17.7 - $33.24 $24.6 Million - $46.3 Million
1,392,114 Added 377.71%
1,760,683 $32.9 Million
Q4 2022

Feb 14, 2023
SELL
$10.25 - $22.43 $11,305 - $24,740
-1,103 Reduced 0.3%
368,569 $7.92 Million
Q3 2022

Nov 15, 2022
BUY
$11.19 - $17.89 $49,415 - $79,002
4,416 Added 1.21%
369,672 $4.37 Million
Q2 2022

Aug 15, 2022
SELL
$9.03 - $21.55 $9.35 Million - $22.3 Million
-1,035,497 Reduced 73.92%
365,256 $4.82 Million
Q1 2022

May 16, 2022
BUY
$15.0 - $22.83 $834,855 - $1.27 Million
55,657 Added 4.14%
1,400,753 $29.3 Million
Q4 2021

Feb 14, 2022
BUY
$20.12 - $35.09 $331,919 - $578,879
16,497 Added 1.24%
1,345,096 $27.3 Million
Q3 2021

Nov 15, 2021
SELL
$23.84 - $32.03 $3.11 Million - $4.18 Million
-130,516 Reduced 8.94%
1,328,599 $40.3 Million
Q2 2021

Aug 16, 2021
BUY
$29.06 - $38.83 $5.32 Million - $7.11 Million
183,209 Added 14.36%
1,459,115 $42.4 Million
Q1 2021

May 17, 2021
SELL
$39.04 - $64.6 $15.5 Million - $25.7 Million
-398,090 Reduced 23.78%
1,275,906 $55.1 Million
Q4 2020

Feb 16, 2021
BUY
$42.46 - $56.58 $16.1 Million - $21.5 Million
380,140 Added 29.38%
1,673,996 $77.3 Million
Q3 2020

Nov 10, 2020
BUY
$37.44 - $64.63 $12 Million - $20.6 Million
319,475 Added 32.79%
1,293,856 $56.1 Million
Q2 2020

Aug 14, 2020
BUY
$17.62 - $58.71 $14.9 Million - $49.8 Million
848,191 Added 672.15%
974,381 $51.7 Million
Q1 2020

May 11, 2020
BUY
$12.26 - $41.14 $1.55 Million - $5.19 Million
126,190 New
126,190 $2.82 Million

Others Institutions Holding BTAI

# of Institutions
55
Shares Held
3.14M
Call Options Held
22.2K
Put Options Held
40.2K
View Full List

About BioXcel Therapeutics, Inc.

BTAI Quotes by TradingView
  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $16M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email